Search
Trastuzumab per al tractament del càncer gàstric o d'unió gastroesofàgica metàstasic HER2+: informe d'avaluació de resultats
(2018)
Trastuzumab is a humanized monoclonal antibody against human epidermal growth factor (HER2) receptor 2, which in 2010 was approved by the European Agency of the
Medication (EMA) for the treatment of gastric cancer or ...
Atezolizumab per al tractament del carcinoma urotelial localment avançat o metastàtic
(2018-10-18)
Urothelial carcinoma (CU) of urinary tract, also known as cell carcinoma transitional of the urinary tract, represents around 85-95% of all the cancers of the urinary tract. The term urothelial refers to the epithelium ...
Ús de recursos i despesa sanitària abans i després d’un ictus agut (10/2018)
(2018-03)
Stroke is an acute disease caused by an alteration of the blood circulation to the brain. From the year 2006 exists, in Catalonia, the stroke Code, which allows you to give a quick and adequate response to these emergencies, ...
Brentuximab vedotina per al tractament de la malaltia de Hodgkin: informe d'avaulació de resultats
(2018)
Lymphoma or Hodgkin's disease is a neoplasm that affects the lymphatic tissue. Symptomatology includes the growth of lymph nodes, spleen and other immune tissues, as well as fever, weight loss, fatigue, night sweats and ...
Ús de recursos i despesa sanitària dels pacients en atenció domiciliària: any 2016 (13/2018)
(2018-03)
Home health care services (ATDOM) are aimed at people who, due to age, dependence or disability, have limited autonomy to perform the basic activities of daily living and require healthcare in the environment of home ...
Persones amb diabetis mellitus tipus 1 i 2 a Catalunya (23/2018)
(2018-11)
Diabetes mellitus (DM) is a chronic disease of the metabolism, increasing prevalence, which with hyperglycemia due to a relative or absolute lack of insulin. Left to free evolution is important cause of morbidity and ...
Propiverina per al tractament dels símptomes urinaris en la síndrome de bufeta hiperactiva
(2018-09-26)
Hyperactive bladder syndrome (SBH) is characterized by urinary urge, with urinary incontinence (UU) of urgency or without, with absence of infection or of another obvious pathology, and that is usually associated with an ...
Lesinurad per al tractament de la hiperuricèmia en pacients amb gota
(2018-04-04)
Gout is a chronic, disabling pathology caused by monosodium urate crystal diposit (UMS) and the resulting inflammation of the articular, periarticular and subcutaneous areas. Associated clinical manifestations are recurrent ...